Novoglan Clinical Evidence

Clinical Evidence for Novoglan Non-Surgical Treatment of Adult Phimosis

The Novoglan device is a foreskin tissue expander designed for the conservative, non-surgical treatment of uncomplicated adult phimosis.

Our growing body of clinical and real-world evidence includes prospective clinical research, post-market surveillance, long-term follow-up, usability data and patient-reported outcomes. The evidence presented below has been shared through international urology, sexual medicine and andrology conferences since 2022 and consistently through today with 24 accepted and/or presented abstracts and clinical research presentations.

This evidence library provides healthcare professionals, researchers and interested patients with access to conference abstracts and presentations, together with published journal research where available covering the safety, efficacy, tolerability and usability of Novoglan for adult phimosis.

Explore the evidence below and access the individual abstracts for further detail.

Explore the Novoglan Clinical Evidence

01 — Clinical Evidence for Adult Phimosis — Clinical trial, safety, efficacy, tolerability and patient-centred evidence.

02 — Long-Term Clinical Outcomes — Two-year follow-up and longer-term efficacy and safety findings.

03 — Real-World Evidence & Patient Outcomes — Post-market surveillance and outcomes from real-world Novoglan users.

04 — Latest 2026 Clinical Evidence — The latest Novoglan clinical research and conference presentations.

05 — Additional Clinical & Conference Evidence — Further research presented across international urology, andrology and sexual medicine meetings.

06 — The Novoglan Circular — Clinical updates, research and educational content for healthcare professionals.

07 — Novoglan Practice Pack — Request a Practice Pack for clinical demonstration and education, subject to qualification and regional availability.

Explore More HCP Resources

Clinical Brochure

Our HCP clinical brochure brings together key information on adult phimosis, patient selection, Kikiros classification, tissue-expansion science, treatment considerations and clinical evidence in one concise resource.

[VIEW THE CLINICAL BROCHURE]

Novoglan Practice Pack

Healthcare professionals can register their interest in receiving a free Novoglan Practice Pack for clinical demonstration and education, subject to a qualification process.

[REGISTER FOR THE NOVOGLAN PRACTICE PACK ]

Clinical Evidence for Novoglan in Adult Phimosis

What does the clinical evidence show about Novoglan for adult phimosis?

Patient-Centred Clinical and Real-World Evidence for Novoglan

This abstract brings together experiential and clinical data examining the safety, efficacy, tolerability, and usability of the Novoglan tissue expander for the foreskin in uncomplicated adult phimosis.

[Abstract PDF – Patient-Centred Review]

What did the Novoglan-01 clinical trial find?

Novoglan-01: Clinical Trial Evidence for Non-Surgical Adult Phimosis Treatment

The Novoglan-01 clinical trial investigated the safety, efficacy and tolerability of the Novoglan device as a non-surgical treatment approach for adult phimosis.

[Novoglan-01 UAA 2022 Abstract]

[View the published TAU Journal article]

How safe and effective is Novoglan for adult phimosis?

Safety, Efficacy and Tolerability of Two Generations of the Novoglan Device

This research examines the efficacy, tolerability and safety of two generations of the Novoglan device in adults with phimosis.

[UAA 2023 Abstract]

[View The Published Abstract]

What does clinical trial and post-market evidence show about Novoglan?

Clinical Trial and Post-Market Evidence for Conservative Treatment of Adult Phimosis

This abstract compares clinical trial findings with post-marketing data relating to the use of Novoglan for conservative treatment of adult phimosis.

[UAA 2023 Clinical Trial and Post-Market Data]

Can Novoglan improve sexual comfort in men with phimosis?

Novoglan Treatment and Pain During Sexual Activity in Adult Men With Phimosis

This research examines the safety and effectiveness of Novoglan treatment and its reported impact on pain during sexual activity in adult males with phimosis.

[View Published Abstract]
[AUA 2023 Abstract PDF]

What does comparative clinical and post-market evidence show?

Comparative Clinical and Real-World Evidence for Novoglan Foreskin Tissue Expansion

This EAU presentation compares independent clinical trial data with post-market surveillance data relating to the Novoglan foreskin tissue expander for adult phimosis.

[EAU 2023 Abstract]

Can non-surgical phimosis treatment affect psychological and sexual wellbeing?

Psychological Outcomes and Sexual Satisfaction Following Novoglan Treatment

This research examines psychological outcomes and sexual satisfaction among males with phimosis following Novoglan foreskin tissue expansion treatment.

[WMSM 2023 Abstract]

Why is early diagnosis and treatment of uncomplicated phimosis important?

Early Diagnosis and Treatment of Uncomplicated Adult Phimosis

This presentation explores early diagnosis and treatment considerations for uncomplicated phimosis and the role of conservative treatment.

[UROGPS 2024 Abstract]

Long-Term Clinical Outcomes

What are the long-term outcomes following Novoglan treatment?

Two-Year Follow-Up Outcomes Following Novoglan Phimosis Treatment

This study presents two-year follow-up outcomes following Novoglan treatment for adult phimosis, providing additional insight into longer-term treatment outcomes.

[USANZ 2024 Two-Year Follow-Up Abstract]

What does long-term efficacy and safety data show?

Long-Term Efficacy and Safety of Novoglan for Adult Phimosis

This research compares outcomes across post-market surveillance, clinical trial data and two-year follow-up to examine the longer-term efficacy and safety of Novoglan treatment.

[AUA Long-Term Efficacy and Safety Abstract]

Real-World Evidence and Patient Outcomes

How does Novoglan perform in real-world clinical use?

Short- and Long-Term Novoglan Outcomes: Clinical Trial Data Compared With 811 Real-World Patients

This research compares clinical trial findings with real-world outcomes from 811 patients, examining the short- and long-term efficacy, safety and usability of Novoglan for adult phimosis.

[UAA 2025 Abstract]

What are the psychological and sexual outcomes following Novoglan treatment?

Psychological and Sexual Outcomes Following Novoglan Treatment: Clinical Trial, Post-Market and Long-Term Follow-Up Evidence

This research examines psychological outcomes and sexual satisfaction following Novoglan treatment using comparative clinical trials, post-market surveillance and follow-up data.

[SMSNA 2026 Abstract – Spanish]

Latest 2026 Clinical Evidence

What are the latest clinical outcomes from the Novoglan-01 trial?

Updated Outcomes From the Novoglan-01 Clinical Trial

This 2026 abstract presents updated outcomes from the Novoglan-01 clinical trial investigating Novoglan as a non-surgical treatment for adult phimosis.

[USANZ 2026 – Updated Novoglan-01 Outcomes]

Can Novoglan reduce the psychosexual burden associated with phimosis?

Novoglan for Reducing Psychosexual Burden in Patients Awaiting Circumcision

This 2026 research examines the use of Novoglan in patients awaiting circumcision in a public hospital and its potential role in reducing the psychosexual burden associated with phimosis.

[WMSM 2026 Abstract]

What are the outcomes of Novoglan use in public hospitals?

Novoglan Device Use in Public Hospitals: Clinical Outcomes and Experience

This 2026 abstract examines the use of the Novoglan device in a public hospital setting, providing evidence from clinical use outside a traditional private treatment pathway.

[USANZ 2026 – Public Hospital Outcomes]

How does Novoglan compare with circumcision as a treatment option?

Novoglan as a Non-Surgical Alternative to Circumcision for Adult Phimosis

This 2026 research compares outcomes from prospective Australian and UK studies examining Novoglan as a non-surgical alternative to circumcision for adult phimosis.

[UAA 2026 Abstract]

What are the latest UK outcomes for Novoglan?

First UK Outcomes of a Non-Surgical Treatment for Adult Phimosis

This research presents early UK outcomes examining the safety, efficacy and tolerability of the Novoglan device as a non-surgical treatment option for adult phimosis.

[View Published Abstract]

[UK Outcomes Abstract]

Additional Clinical and Conference Evidence

How has Novoglan been evaluated across clinical and experiential data?

A Patient-Centred Review of Novoglan Safety, Efficacy, Tolerability and Usability

A broader review of experiential and clinical evidence examining the Novoglan foreskin tissue expander for uncomplicated adult phimosis.

[Patient-Centred Evidence Review]

What evidence has been presented internationally?

Novoglan evidence has been presented across major international urology, andrology and sexual medicine meetings, including the UAA, EAU, AUA, USANZ, WMSM and SMSNA.

The collection includes research addressing the following:

Safety and tolerability
Treatment efficacy
Foreskin preservation
Device usability
Patient-reported outcomes
Sexual and psychological outcomes
Clinical trial findings
Post-market surveillance
Long-term follow-up
Real-world treatment outcomes
UK and Australian clinical experience
Use in public hospital settings

View More Data

The Novoglan Circular

Clinical Updates and Evidence for Healthcare Professionals

The Novoglan Circular is our healthcare professional-focused newsletter, sharing updates on clinical evidence, research, phimosis management and developments in non-surgical foreskin-preserving treatment.

Clinicians can follow the Novoglan Circular on LinkedIn to stay up to date with new evidence, conference presentations, clinical insights and developments relevant to adult phimosis management.

[Follow the Novoglan Circular on LinkedIn]

Novoglan Practice Pack

What Does the Novoglan Practice Pack Include for HCPs?

Healthcare professionals can request a Novoglan HCP Practice Pack for professional demonstration and education, subject to HCP verification, qualification and regional availability.” Confirm “provided at no charge” only after HCP verification.

The Practice Pack is designed to help clinicians understand how the Novoglan device works and how it may be incorporated into conversations around conservative, foreskin-preserving treatment for appropriate patients.

The pack can include:

Novoglan demonstration device
Product and treatment information
Instructions for use
Clinical evidence materials
Healthcare professional educational resources
Patient information materials
Information on Novoglan treatment and tissue expansion

Availability and pack contents may vary by market.

Learn More About Novoglan

Interested in Learning More or Requesting a Practice Pack?

If you want to learn more about Novoglan or register for a free Novoglan Practice Pack for demonstration, please feel free to reach out.

Contact us